UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 738

Sortiert nach

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Gene therapy, 2000-05, Vol.7 (10), p.867-874

2000

Volltextzugriff (PDF)

Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures

Gene therapy, 2009-12, Vol.16 (12), p.1477-1482

2009

Volltextzugriff (PDF)

Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain

Gene therapy, 2005-04, Vol.12 (8), p.647-654

2005

Volltextzugriff (PDF)

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer

Gene therapy, 2010-06, Vol.17 (6), p.805-810

2010

Volltextzugriff (PDF)

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect

Gene therapy, 2009-07, Vol.16 (7), p.905-915

2009

Volltextzugriff (PDF)

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

Neuro-oncology (Charlottesville, Va.), 2012-02, Vol.14 (2), p.132-144

2012

Volltextzugriff (PDF)

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers

Cancer gene therapy, 2006-03, Vol.13 (3), p.253-265

2006

Volltextzugriff (PDF)

Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells

Cancer gene therapy, 2009-07, Vol.16 (7), p.551-560

2009

Volltextzugriff (PDF)

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

Human gene therapy, 1999-11, Vol.10 (17), p.2741-2755

1999

Volltextzugriff (PDF)

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice

Gene therapy, 1999-10, Vol.6 (10), p.1751-1758

1999

Volltextzugriff (PDF)

Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine

Gene therapy, 2001-02, Vol.8 (4), p.332-339

2001

Volltextzugriff (PDF)

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207

Human gene therapy, 1999-09, Vol.10 (13), p.2237-2243

1999

Volltextzugriff (PDF)

Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

Cancer gene therapy, 2013-01, Vol.20 (1), p.17-24

2013

Volltextzugriff (PDF)

Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex

Nature (London), 2003-07, Vol.424 (6946), p.316-320

2003

Volltextzugriff (PDF)

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

Gene therapy, 1999-04, Vol.6 (4), p.564-572

1999

Volltextzugriff (PDF)

Treatment of breast cancer stem cells with oncolytic herpes simplex virus

Cancer gene therapy, 2012-10, Vol.19 (10), p.707-714

2012

Volltextzugriff (PDF)

Preproenkephalin Promoter Yields Region-Specific and Long-Term Expression in Adult Brain after Direct in vivo Gene Transfer via a Defective Herpes Simplex Viral Vector

Proceedings of the National Academy of Sciences - PNAS, 1994-09, Vol.91 (19), p.8979-8983

1994

Volltextzugriff (PDF)

Oncolytic herpes simplex virus vectors for cancer virotherapy

Cancer gene therapy, 2002-12, Vol.9 (12), p.967-978

2002

Volltextzugriff (PDF)

Oncolytic Herpes Simplex Virus Vector with Enhanced MHC Class I Presentation and Tumor Cell Killing

Proceedings of the National Academy of Sciences - PNAS, 2001-05, Vol.98 (11), p.6396-6401

2001

Volltextzugriff (PDF)

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (21), p.4752-4756

1995

Volltextzugriff (PDF)

Transcriptional targeting of herpes simplex virus for cell-specific replication

Journal of Virology, 1997-07, Vol.71 (7), p.5124-5132

1997

Volltextzugriff (PDF)

Preclinical safety evaluation of g207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

Human gene therapy, 2001-05, Vol.12 (8), p.999-1010

2001

Volltextzugriff (PDF)

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy

Human gene therapy, 1999-11, Vol.10 (17), p.2869-2878

1999

Volltextzugriff (PDF)

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide

Molecular pharmacology, 1996-08, Vol.50 (2), p.236

1996

Volltextzugriff (PDF)

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

Nature medicine, 1995-09, Vol.1 (9), p.938-943

1995

Volltextzugriff (PDF)

1 – 25 von 738

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(651)
Mit Volltextzugriff
(545)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures

Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers

Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice

Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207

Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

Treatment of breast cancer stem cells with oncolytic herpes simplex virus

Preproenkephalin Promoter Yields Region-Specific and Long-Term Expression in Adult Brain after Direct in vivo Gene Transfer via a Defective Herpes Simplex Viral Vector

Oncolytic herpes simplex virus vectors for cancer virotherapy

Oncolytic Herpes Simplex Virus Vector with Enhanced MHC Class I Presentation and Tumor Cell Killing

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1

Transcriptional targeting of herpes simplex virus for cell-specific replication

Preclinical safety evaluation of g207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

Suchergebnisse filtern